Address And Details

12760 High Bluff Drive, Suite 280 , San Diego, CA 92130
Fund Manager Michael Krause
Manager Tenure 5 Years 10 Months

Strategy And Objective

The Counter point Tactical Equity Fund (the Fund ) seeks capital appreciation and preservation.Under normal market conditions,the Fund invests at least 80% of its assets (plus the amount of borrowings,if any) in long and short positions in equity instruments of any market capitalization.Equity instruments include domestic and foreign common stock,preferred stock,depositary receipts,equity swaps (including single-name,index,and basket swaps),options,equity index futures,and other investment companies (such as exchange traded finds ( ETFs ),mutual funds,and closed-end funds) thatinvest in these types of securities.The Fund may hedge exposure to foreign currencies using foreign currency forwards or futures.In managing the Fund,the Fund s adviser, Counter point Mutual Funds,LLC (the Adviser ),employs a strategy that generates returns from two sources: (1) stock selection and (2)tactical market exposure.Stock Selection.The Adviser selects the particular stocks on which to go long and short based on multi-factor quantitative models.The models are based on proprietary research related to economic indicators and investment a nomalies found in peer-reviewed academic journals.An investment anomaly refers to a situation when a security or group of securities performs contrary to the notion of efficient markets,which states that security prices reflect all available information at any point in time.Published papers in academic finance journals have identified more than one hundred investment anomalies.An example of such an anomaly would be the asset growth anomaly where the literature has shown that companies that are more aggressive with spending their capital have worse average stock performance than companies that are more conservative in their capital expenditures.Perfect market efficiency would not yield any market outperformance from investment decisions based on publicly available accounting data such as this.The Fund seeks to target the best performing,recent,and persistent anomalies.The Fund may invest in stocks that provide exposure to a wide variety of anomalies.The Adviser sstrategy may seek to capitalize on many market anomalies at any one time.The Adviser may adjust its model to include newer and more effective anomalies and pare down exposure to older under performing anomalies on a regular basis.The signals from these models indicate which stocks are undervalued and likely to increase in price and which stocks are overvalued and likely to decrease in price.The Adviser takes long positions in the undervalued securities and short positions in the overvalued securities.

Net Asset Value

as of 5:22 PM ET 09/17/2021

Performance

  • 1 Week
  • +0.62%
  • 1 Month
  • -4.29%
  • 3 Months
  • +14.82%
  • 1 Yr Return
  • +10.69%
  • 5 Yr Return
  • -19.90%

Equity Sector Breakdown

Finance 2.91%
ConsumerDurables n/a
Energy n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 97.09%
Other 2.91%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 10.94 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -11.98 -6.31 n/a
Beta 0.17 0.23 n/a
R Squared 0.04 0.07 n/a
Std Deviation 15.74 13.21 n/a
Sharpe Ratio -0.59 -0.20 n/a

Purchase Information

as of 5:37 PM ET 09/16/2021
Minimum Initial $100000
Minimum Additional $1000
Minimum Initial IRA $100000

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +9.48%
  • -2.13%
+9.48% -2.13%
3 Year
  • -9.42%
  • -12.08%
-9.42% -12.08%
10 Year
  • n/a
  • n/a
n/a n/a
Life Of Fund
  • -2.93%
  • -5.34%
-2.93% -5.34%

Top 10 Holdings

Symbol Company Name % Of Assets
SPY SPDR S&P 500 TRUST ETF 2.91%

Recent Articles from TheStreet

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Watch Live: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.

Evergrande Group Lead

China Faces 'Lehman Moment' With Evergrande Collapse, So What Are The Risks?

'Lehman moment' or managed failure? Either result has global markets rattled by the impending default of property developer China Evergrande.

210810Corn_1600x900_1200x628

As Demand for Corn Grows, New Key Data Points to Watch

What data should corn market watchers seek out in a tight market? A new volatility gauge offers some answers.

Pfizer vaccine Lead

Pfizer Says Its COVID Vaccine Safe For Children 5 to 11 In Lower Doses

"These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency," said Pfizer CEO Albert Bourla.